Cases & Deals

Abbott acquires Facet Biotech for $722 million

Clients Abbott Laboratories

Jones Day advised Abbott Laboratories in its acquisition of Facet Biotech Corporation for $27 per share in cash for a net transaction value of approximately $450 million, which includes a purchase price of approximately $722 million less Facet's projected cash and marketable securities at closing of approximately $272 million. The acquisition brings access to biologics in two key therapeutic areas, immunology and oncology.

In addition to M&A representation, Jones Day provided antitrust, benefits, regulatory, and IP advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.